Rationale and design of the Arterial Disease Multiple Intervention Trial (ADMIT) pilot study. (Q53347765)

13 May 2018

title

Rationale and design of the Arterial Disease Multiple Intervention Trial (ADMIT) pilot study. (English)

1 reference

13 May 2018

author name string

Egan DA

1

1 reference

13 May 2018

Garg R

2

1 reference

13 May 2018

Wilt TJ

3

1 reference

13 May 2018

Pettinger MB

4

1 reference

13 May 2018

Davis KB

5

1 reference

13 May 2018

Crouse J

6

1 reference

13 May 2018

Herd JA

7

1 reference

13 May 2018

Hunninghake DB

8

1 reference

13 May 2018

Sheps DS

9

1 reference

13 May 2018

Kostis JB

10

1 reference

13 May 2018

Probstfield J

11

1 reference

13 May 2018

Waclawiw MA

12

1 reference

13 May 2018

Applegate W

13

1 reference

13 May 2018

Elam MB

14

1 reference

13 May 2018

language of work or name

English

0 references

publication date

1 February 1999

1 reference

13 May 2018

American Journal of Cardiology

published in

1 reference

13 May 2018

volume

83

1 reference

13 May 2018

page(s)

569-575

1 reference

13 May 2018

issue

4

1 reference

13 May 2018

Serum lipoprotein (a) levels in men with peripheral vascular disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900915-1

Lipoprotein profile in men with peripheral vascular disease. Role of intermediate density lipoproteins and apoprotein E phenotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900915-1

Antioxidants in the prevention of human atherosclerosis. Summary of the proceedings of a National Heart, Lung, and Blood Institute Workshop: September 5-6, 1991, Bethesda, Maryland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900915-1

Dietary antioxidants and cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900915-1

The ratio of ankle and arm arterial pressure as an independent predictor of mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900915-1

The Edinburgh Claudication Questionnaire: an improved version of the WHO/Rose Questionnaire for use in epidemiological surveys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900915-1

Contrasting effects of unmodified and time-release forms of niacin on lipoproteins in hyperlipidemic subjects: clues to mechanism of action of niacin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900915-1

A comparison of the efficacy and toxic effects of sustained- vs immediate-release niacin in hypercholesterolemic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900915-1

Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900915-1

Lovastatin, nicotinic acid, and rhabdomyolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900915-1

Myolysis and acute renal failure in a heart-transplant recipient receiving lovastatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900915-1

Effects of pravastatin in patients with serum total cholesterol levels from 5.2 to 7.8 mmol/liter (200 to 300 mg/dl) plus two additional atherosclerotic risk factors. The Pravastatin Multinational Study Group for Cardiac Risk Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900915-1

Vitamin E consumption and the risk of coronary heart disease in men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900915-1

Antioxidants in adipose tissue and risk of myocardial infarction: the EURAMIC Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900915-1

Vitamin C intake and mortality among a sample of the United States population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900915-1

The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900915-1

Aspirin as a therapeutic agent in cardiovascular disease. Special Writing Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900915-1

A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900915-1

Final report on the aspirin component of the ongoing Physicians' Health Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900915-1

Obliterative arterial disease of the lower limbs. IV. Evaluation of long-term anticoagulant therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900915-1

The effect of warfarin on mortality and reinfarction after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900915-1

Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900915-1

10.1016/S0002-9149(98)00915-1

7 January 2021

Identifiers

DOI

1 reference

13 May 2018

PubMed ID

10073863

1 reference

13 May 2018